NeuroTherapia, Inc.
PrivateLast Round
Series B
Aug 6, 2024
Total Funding Raised
$11.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroTherapia, Inc. operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Series A round in September 2020.
NeuroTherapia, Inc. is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system, including Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroTherapia, Inc. Comparables
Compare NeuroTherapia, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerevance | 82% | |
| Tranquis Therapeutics | 82% | |
| Neusignal Therapeutics, Inc. | 81% |
For institutional investors. Book with your work email.
NeuroTherapia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2024 | ||||
| Series A | Sep 22, 2020 | ||||
| Grant | Sep 21, 2016 | ||||
| Seed | Oct 13, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroTherapia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brain Trust Accelerator Fund | Series B, Series A |
| Dolby Family Ventures | Series B, Series A |
| Cleveland Clinic Ventures | Series B, Series A |
| The Foundation For A Better World | Series B |
| Alzheimer's Drug Discovery Foundation | Series B, Series A, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 228% MoM, reaching 1K.
- Aug 6, 2024
$12M round led by Cleveland Clinic
For institutional investors. Book with your work email.
NeuroTherapia, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroTherapia, Inc.'s valuation, stock price, and market status.
Is NeuroTherapia, Inc. a public or private company?
NeuroTherapia, Inc. is a private company.
What is the current stock price of NeuroTherapia, Inc.?
NeuroTherapia, Inc. is a private company, so its shares have no public market price. Caplight tracks NeuroTherapia, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroTherapia, Inc. worth (valuation)?
Valuation information for NeuroTherapia, Inc. is not publicly available.
Can I buy NeuroTherapia, Inc. stock?
NeuroTherapia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroTherapia, Inc.'s last funding round?
NeuroTherapia, Inc.'s most recent funding round was Series B on August 6, 2024.
Who are the main investors in NeuroTherapia, Inc.?
Key investors in NeuroTherapia, Inc. include Brain Trust Accelerator Fund, Cleveland Clinic Ventures.
Will NeuroTherapia, Inc. IPO soon?
No public IPO plans have been announced for NeuroTherapia, Inc..
How can I track NeuroTherapia, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NeuroTherapia, Inc.'s shares on secondary markets.